Although there are conflicting reports in the literature with regard to the methylation of the RASSF1 gene in ovarian tumors, our results are in agreement with the findings of Agathanggelou et al (49), which showed that RASSF1 is methylated in 10% of ovarian cancer cases, irrespective of grade. This evidence concerns the gene RASSF1 and ovarian cancer.